Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/1990
Title: | Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls | Authors: | VANDERLOCHT, Joris HENDRIKS, Jerome VENKEN, Koen STINISSEN, Piet HELLINGS, Niels |
Issue Date: | 2006 | Publisher: | ELSEVIER SCIENCE BV | Source: | JOURNAL OF NEUROIMMUNOLOGY, 177(1-2). p. 189-200 | Abstract: | In multiple sclerosis (MS), oligodendrocyte injury is believed to be caused by an aberrant immune response initiated by autoreactive T cells. Increasing evidence indicates that inflammatory responses in the central nervous system are not exclusively detrimental, but may also exert protective effects. Such protective effects are potentially mediated by the local secretion of neurotrophic factors by immune cells. We previously reported that T cells and monocytes in vitro and in inflammatory MS lesions produce leukaemia inhibitory factor (LIF), a member of the neuropoietic family of neurotrophins. In the present study, we report a reduced LIF production by CD4(+) T cells of relapsing remitting MS patients as compared to healthy controls. Furthermore, immunomodulatory agents such as leptin, IFN-beta and simvastatin were studied for their potential to alter LIF and secretion of other cytokines by T cells and monocytes of relapsing remitting MS patients and healthy controls. Low doses of simvastatin, but not IFN-beta or leptin enhanced LIF secretion by CD4+ T cells of RR-MS patients. We further demonstrated that LIF did not influence viability, proliferation and cytokine secretion of T cells. Together these data provide new information on the regulation of LIF secretion by immune cells. Further insights into the complex regulation of neurotrophic factors such as LIF may prove useful for treatment of MS. (c) 2006 Elsevier B.V All rights reserved. | Notes: | Hasselt Univ, Biomed Onderzoeksinst, B-3590 Diepenbeek, Belgium. Trasnatl Univ Limburg, Sch Life Sci, Diepenbeek, Belgium.Hellings, N, Hasselt Univ, Biomed Onderzoeksinst, Agoralaan Bldg A, B-3590 Diepenbeek, Belgium.niels.hellings@uhasselt.be | Keywords: | multiple sclerosis; neuroprotection; leukemia inhibitory factor; immunotherapy | Document URI: | http://hdl.handle.net/1942/1990 | ISSN: | 0165-5728 | e-ISSN: | 1872-8421 | DOI: | 10.1016/j.jneuroim.2006.04.012 | ISI #: | 000240261100022 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2007 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
13
checked on Sep 7, 2020
WEB OF SCIENCETM
Citations
14
checked on Oct 14, 2024
Page view(s)
50
checked on Jun 14, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.